The Delhi High Court on Monday deferred its hearing on a petition challenging an advisory issued by the Indian Council of Medical Research (ICMR), barring repetition of RT-PCR tests on individuals who tested positive for Covid-19.
The Delhi High Court's directions to National Centre for Disease Control came after it was informed by Amicus Curiae Rajshekhar Rao that there is a need to study the effectiveness of several medications prescribed and administered by the practicing doctor.
The petition has been filed by a practising advocate in Delhi who was tested positive along with his parents but have mild symptoms and home quarantined for 17 months
The Delhi High Court on Tuesday dismissed a writ petition seeking modification of Covid-19 treatment protocol for mild cases with a cost of Rs 25,000, saying the petition though filed as a Public Interest Litigation is nothing but Publicity Interest Litigation.
While the manufacturer of Covaxin got itself in a jam with Brazil following an inspection of its Hyderabad facility, AstraZeneca’s vaccine was put on hold in several nations after reports of blood clots. How safe are these vaccines?
Even as many nations are battling the deadly pandemic, India, a world leader in health, has lent a helping hand by exporting vaccines to them. This diplomatic move could also help in medical tourism.